{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:19:41Z","timestamp":1777537181767,"version":"3.51.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s10689-023-00340-5","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T06:02:01Z","timestamp":1687154521000},"page":"499-511","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical and imaging modality factors impacting radiological interpretation of breast screening in young women with neurofibromatosis type 1"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6054-039X","authenticated-orcid":false,"given":"Mathilda","family":"Wilding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1164-2386","authenticated-orcid":false,"given":"Jane","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4382-6702","authenticated-orcid":false,"given":"Katrina","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5578-0460","authenticated-orcid":false,"given":"Ashley","family":"Crook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranjani","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7746-9649","authenticated-orcid":false,"given":"Timothy E.","family":"Schlub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7455-934X","authenticated-orcid":false,"given":"Michael","family":"Field","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8415-9371","authenticated-orcid":false,"given":"Lavvina","family":"Thiyagarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2495-4928","authenticated-orcid":false,"given":"Yemima","family":"Berman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,19]]},"reference":[{"issue":"2","key":"340_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ajmg.a.33139","volume":"152","author":"D Evans","year":"2010","unstructured":"Evans D, Howard E, Giblin C et al (2010) Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet Part A 152(2):327\u2013332","journal-title":"Am J Med Genet Part A"},{"issue":"1","key":"340_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/archderm.141.1.71","volume":"141","author":"M Lammert","year":"2005","unstructured":"Lammert M, Friedman JM, Kluwe L, Mautner VF (2005) Prevalence of neurofibromatosis 1 in german children at elementary school enrollment. Arch Dermatol 141(1):71\u201374. https:\/\/doi.org\/10.1001\/archderm.141.1.71","journal-title":"Arch Dermatol"},{"issue":"9","key":"340_CR3","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/gim.2017.215","volume":"20","author":"RA Kallionpaa","year":"2018","unstructured":"Kallionpaa RA, Uusitalo E, Leppavirta J, Poyhonen M, Peltonen S, Peltonen J (2018) Prevalence of neurofibromatosis type 1 in the finnish population. Genet Med 20(9):1082\u20131086. https:\/\/doi.org\/10.1038\/gim.2017.215","journal-title":"Genet Med"},{"issue":"8","key":"340_CR4","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1136\/jmg.37.8.632","volume":"37","author":"M Poyhonen","year":"2000","unstructured":"Poyhonen M, Kytola S, Leisti J (2000) Epidemiology of neurofibromatosis type 1 (NF1) in northern finland. J Med Genet 37(8):632\u2013636. https:\/\/doi.org\/10.1136\/jmg.37.8.632","journal-title":"J Med Genet"},{"key":"340_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-021-01170-5","author":"E Legius","year":"2021","unstructured":"Legius E, Messiaen L, Wolkenstein P et al (2021) Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet Med. https:\/\/doi.org\/10.1038\/s41436-021-01170-5","journal-title":"Genet Med"},{"issue":"8","key":"340_CR6","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1177\/088307380201700802","volume":"17","author":"JM Friedman","year":"2002","unstructured":"Friedman JM (2002) Neurofibromatosis 1: clinical manifestations and diagnostic criteria. J Child Neurol 17(8):548\u2013554. https:\/\/doi.org\/10.1177\/088307380201700802. discussion 71-2, 646-51","journal-title":"J Child Neurol"},{"issue":"17","key":"340_CR7","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1200\/JCO.2015.65.3576","volume":"34","author":"E Uusitalo","year":"2016","unstructured":"Uusitalo E, Rantanen M, Kallionpaa RA et al (2016) Distinctive Cancer Associations in patients with neurofibromatosis type 1. J Clin Oncol 34(17):1978\u20131986. https:\/\/doi.org\/10.1200\/JCO.2015.65.3576","journal-title":"J Clin Oncol"},{"issue":"11","key":"340_CR8","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/ejhg.2011.113","volume":"19","author":"DG Evans","year":"2011","unstructured":"Evans DG, O\u2019Hara C, Wilding A et al (2011) Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989. Eur J Hum Genet 19(11):1187\u20131191. https:\/\/doi.org\/10.1038\/ejhg.2011.113","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"340_CR9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1136\/jmedgenet-2011-100562","volume":"49","author":"A Wilding","year":"2012","unstructured":"Wilding A, Ingham SL, Lalloo F et al (2012) Life expectancy in hereditary cancer predisposing diseases: an observational study. J Med Genet 49(4):264\u2013269. https:\/\/doi.org\/10.1136\/jmedgenet-2011-100562","journal-title":"J Med Genet"},{"issue":"5","key":"340_CR10","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1086\/320121","volume":"68","author":"SA Rasmussen","year":"2001","unstructured":"Rasmussen SA, Yang Q, Friedman JM (2001) Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet 68(5):1110\u20131118. https:\/\/doi.org\/10.1086\/320121","journal-title":"Am J Hum Genet"},{"issue":"2","key":"340_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/bjc.2016.403","volume":"116","author":"E Uusitalo","year":"2017","unstructured":"Uusitalo E, Kallionpaa RA, Kurki S et al (2017) Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors. Br J Cancer 116(2):211\u2013217. https:\/\/doi.org\/10.1038\/bjc.2016.403","journal-title":"Br J Cancer"},{"key":"340_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13053-019-0110-z","volume":"17","author":"LP Suarez-Kelly","year":"2019","unstructured":"Suarez-Kelly LP, Yu L, Kline D, Schneider EB, Agnese DM, Carson WE (2019) Increased breast cancer risk in women with neurofibromatosis type 1: a meta-analysis and systematic review of the literature. Hered Cancer Clin Pract 17:12. https:\/\/doi.org\/10.1186\/s13053-019-0110-z","journal-title":"Hered Cancer Clin Pract"},{"issue":"5","key":"340_CR13","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1038\/bjc.2013.6","volume":"108","author":"S Walters","year":"2013","unstructured":"Walters S, Maringe C, Butler J et al (2013) Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000\u20132007: a population-based study. Br J Cancer 108(5):1195\u20131208. https:\/\/doi.org\/10.1038\/bjc.2013.6","journal-title":"Br J Cancer"},{"key":"340_CR14","doi-asserted-by":"publisher","unstructured":"Carton C, Evans DG, Blanco I et al (2023) ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1. eClinicalMedicine 56. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101818","DOI":"10.1016\/j.eclinm.2022.101818"},{"key":"340_CR15","unstructured":"eviQ Cancer Treatments Online (2023) Cancer Institute NSW, viewed 1 March 2023. https:\/\/www.eviq.org.au\/"},{"key":"340_CR16","unstructured":"Daly MB, Pal T, AlHilli Z et al (2023) Genetic\/Familial High-Risk Assessment: breast, ovarian, and pancreatic, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 19(1)"},{"issue":"9","key":"340_CR17","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1038\/bjc.2015.78","volume":"112","author":"OO Seminog","year":"2015","unstructured":"Seminog OO, Goldacre MJ (2015) Age-specific risk of breast cancer in women with neurofibromatosis type 1. Br J Cancer 112(9):1546\u20131548. https:\/\/doi.org\/10.1038\/bjc.2015.78","journal-title":"Br J Cancer"},{"issue":"8","key":"340_CR18","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/jmg.2007.049346","volume":"44","author":"S Sharif","year":"2007","unstructured":"Sharif S, Moran A, Huson SM et al (2007) Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening. J Med Genet 44(8):481\u2013484. https:\/\/doi.org\/10.1136\/jmg.2007.049346","journal-title":"J Med Genet"},{"issue":"2","key":"340_CR19","first-page":"398","volume":"22","author":"DGR Evans","year":"2020","unstructured":"Evans DGR, Kallionp\u00e4\u00e4 RA, Clementi M et al (2020) Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study. Genet Sci 22(2):398\u2013406","journal-title":"Genet Sci"},{"key":"340_CR20","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2147\/BCTT.S111397","volume":"9","author":"SJ Howell","year":"2017","unstructured":"Howell SJ, Hockenhull K, Salih Z, Evans DG (2017) Increased risk of breast cancer in neurofibromatosis type 1: current insights. Breast Cancer (Dove Med Press) 9:531\u2013536. https:\/\/doi.org\/10.2147\/BCTT.S111397","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"340_CR21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12885-015-1215-z","volume":"15","author":"AV Da Silva","year":"2015","unstructured":"Da Silva AV, Rodrigues FR, Pureza M, Lopes VG, Cunha KS (2015) Breast cancer and neurofibromatosis type 1: a diagnostic challenge in patients with a high number of neurofibromas. BMC Cancer 15:183. https:\/\/doi.org\/10.1186\/s12885-015-1215-z","journal-title":"BMC Cancer"},{"issue":"1","key":"340_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.clbc.2011.07.005","volume":"12","author":"Y Zhou","year":"2012","unstructured":"Zhou Y, Pan B, Mao F et al (2012) A hidden breast lump covered by nipple appendices in a patient with von recklinghausen disease: a case report and review of the literature. Clin Breast Cancer 12(1):71\u201375. https:\/\/doi.org\/10.1016\/j.clbc.2011.07.005","journal-title":"Clin Breast Cancer"},{"issue":"16","key":"340_CR23","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1200\/JCO.2005.03.8349","volume":"24","author":"S Sharif","year":"2006","unstructured":"Sharif S, Ferner R, Birch JM et al (2006) Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy. J Clin Oncol 24(16):2570\u20132575. https:\/\/doi.org\/10.1200\/JCO.2005.03.8349","journal-title":"J Clin Oncol"},{"key":"340_CR24","doi-asserted-by":"publisher","first-page":"e5660","DOI":"10.1136\/bmj.e5660","volume":"345","author":"A Pijpe","year":"2012","unstructured":"Pijpe A, Andrieu N, Easton DF et al (2012) Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1\/2 mutations: retrospective cohort study (GENE-RAD-RISK). BMJ 345:e5660. https:\/\/doi.org\/10.1136\/bmj.e5660","journal-title":"BMJ"},{"issue":"958","key":"340_CR25","doi-asserted-by":"publisher","first-page":"e234","DOI":"10.1259\/bjr\/33539044","volume":"80","author":"G Gokalp","year":"2007","unstructured":"Gokalp G, Hakyemez B, Kizilkaya E, Haholu A (2007) Myxoid neurofibromas of the breast: mammographical, sonographical and MRI appearances. Br J Radiol 80(958):e234\u2013e237. https:\/\/doi.org\/10.1259\/bjr\/33539044","journal-title":"Br J Radiol"},{"issue":"4","key":"340_CR26","doi-asserted-by":"publisher","first-page":"462","DOI":"10.2484\/rcr.v7i4.462","volume":"7","author":"S Thompson","year":"2012","unstructured":"Thompson S, Kaplan SS, Poppiti RJ Jr, Collado-Mesa F, Rabinovich K (2012) Solitary neurofibroma of the breast. Radiol Case Rep 7(4):462. https:\/\/doi.org\/10.2484\/rcr.v7i4.462","journal-title":"Radiol Case Rep"},{"key":"340_CR27","doi-asserted-by":"publisher","unstructured":"Maani N, Westergard S, Yang J et al (2019) NF1 patients receiving breast Cancer screening: insights from the Ontario High Risk breast screening program. Cancers (Basel) 11(5). https:\/\/doi.org\/10.3390\/cancers11050707","DOI":"10.3390\/cancers11050707"},{"issue":"1","key":"340_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10549-016-4090-7","volume":"162","author":"JO Wanders","year":"2017","unstructured":"Wanders JO, Holland K, Veldhuis WB et al (2017) Volumetric breast density affects performance of digital screening mammography. Breast Cancer Res Treat 162(1):95\u2013103. https:\/\/doi.org\/10.1007\/s10549-016-4090-7","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"340_CR29","doi-asserted-by":"publisher","first-page":"e222575","DOI":"10.1148\/radiol.222575","volume":"306","author":"RJ Acciavatti","year":"2023","unstructured":"Acciavatti RJ, Lee SH, Reig B et al (2023) Beyond breast density: risk measures for breast Cancer in multiple imaging modalities. Radiology 306(3):e222575. https:\/\/doi.org\/10.1148\/radiol.222575","journal-title":"Radiology"},{"issue":"1","key":"340_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1177\/1087054712450749","volume":"19","author":"VF Mautner","year":"2015","unstructured":"Mautner VF, Granstrom S, Leark RA (2015) Impact of ADHD in adults with neurofibromatosis type 1: associated psychological and social problems. J Atten Disord 19(1):35\u201343. https:\/\/doi.org\/10.1177\/1087054712450749","journal-title":"J Atten Disord"},{"key":"340_CR31","doi-asserted-by":"crossref","unstructured":"Ferner RE, Hughes RA, Weinman J (1996) Intellectual impairment in neurofibromatosis 1. J Neurol Sci 138(1\u20132): 125 \u2013 33 DOI 10.1016\/0022-510x(96)00022 \u2013 6","DOI":"10.1016\/0022-510X(96)00022-6"},{"issue":"6","key":"340_CR32","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s10897-015-9829-5","volume":"24","author":"HA Crawford","year":"2015","unstructured":"Crawford HA, Barton B, Wilson MJ et al (2015) The impact of neurofibromatosis type 1 on the Health and Wellbeing of australian adults. J Genet Couns 24(6):931\u2013944. https:\/\/doi.org\/10.1007\/s10897-015-9829-5","journal-title":"J Genet Couns"},{"issue":"3","key":"340_CR33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ejso.2010.12.011","volume":"37","author":"N Biglia","year":"2011","unstructured":"Biglia N, Bounous VE, Martincich L et al (2011) Role of MRI (magnetic resonance imaging) versus conventional imaging for breast cancer presurgical staging in young women or with dense breast. Eur J Surg Oncol (EJSO) 37(3):199\u2013204","journal-title":"Eur J Surg Oncol (EJSO)"},{"issue":"Suppl 1","key":"340_CR34","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.3978\/j.issn.2072-1439.2013.05.02","volume":"5","author":"DS Salem","year":"2013","unstructured":"Salem DS, Kamal RM, Mansour SM, Salah LA, Wessam R (2013) Breast imaging in the young: the role of magnetic resonance imaging in breast cancer screening, diagnosis and follow-up. J Thorac Dis 5(Suppl 1):S9\u2013S18. https:\/\/doi.org\/10.3978\/j.issn.2072-1439.2013.05.02","journal-title":"J Thorac Dis"},{"issue":"13","key":"340_CR35","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/j.ejca.2007.06.007","volume":"43","author":"SJ Lord","year":"2007","unstructured":"Lord SJ, Lei W, Craft P et al (2007) A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer 43(13):1905\u20131917. https:\/\/doi.org\/10.1016\/j.ejca.2007.06.007","journal-title":"Eur J Cancer"},{"issue":"10","key":"340_CR36","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1200\/JCO.2014.56.8626","volume":"33","author":"CC Riedl","year":"2015","unstructured":"Riedl CC, Luft N, Bernhart C et al (2015) Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density. J Clin Oncol 33(10):1128\u20131135. https:\/\/doi.org\/10.1200\/JCO.2014.56.8626","journal-title":"J Clin Oncol"},{"issue":"3","key":"340_CR37","doi-asserted-by":"publisher","first-page":"W292","DOI":"10.2214\/AJR.10.6049","volume":"198","author":"CM Checka","year":"2012","unstructured":"Checka CM, Chun JE, Schnabel FR, Lee J, Toth H (2012) The relationship of mammographic density and age: implications for breast cancer screening. AJR Am J Roentgenol 198(3):W292\u2013W295. https:\/\/doi.org\/10.2214\/AJR.10.6049","journal-title":"AJR Am J Roentgenol"},{"issue":"9","key":"340_CR38","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1093\/aje\/kwn063","volume":"167","author":"LE Kelemen","year":"2008","unstructured":"Kelemen LE, Pankratz VS, Sellers TA et al (2008) Age-specific trends in mammographic density: the Minnesota breast Cancer Family Study. Am J Epidemiol 167(9):1027\u20131036. https:\/\/doi.org\/10.1093\/aje\/kwn063","journal-title":"Am J Epidemiol"},{"key":"340_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-021-00259-9","author":"A Crook","year":"2021","unstructured":"Crook A, Kwa R, Ephraums S et al (2021) The psychological impact and experience of breast cancer screening in young women with an increased risk of breast cancer due to neurofibromatosis type 1. Fam Cancer. https:\/\/doi.org\/10.1007\/s10689-021-00259-9","journal-title":"Fam Cancer"},{"key":"340_CR40","unstructured":"Radiology ACo, D\u2019Orsi CJ (2013) ACR BI-RADS atlas: breast imaging reporting and data system; mammography, ultrasound, magnetic resonance imaging, follow-up and outcome monitoring, data dictionary. ACR, American College of Radiology"},{"issue":"12","key":"340_CR41","doi-asserted-by":"publisher","first-page":"5182","DOI":"10.1007\/s00330-018-5473-4","volume":"28","author":"S Mall","year":"2018","unstructured":"Mall S, Noakes J, Kossoff M et al (2018) Can digital breast tomosynthesis perform better than standard digital mammography work-up in breast cancer assessment clinic? Eur Radiol 28(12):5182\u20135194","journal-title":"Eur Radiol"},{"issue":"7","key":"340_CR42","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.crad.2006.02.008","volume":"61","author":"GJ Porter","year":"2006","unstructured":"Porter GJ, Evans AJ, Lee AH, Hamilton LJ, James JJ (2006) Unusual benign breast lesions. Clin Radiol 61(7):562\u2013569. https:\/\/doi.org\/10.1016\/j.crad.2006.02.008","journal-title":"Clin Radiol"},{"issue":"11","key":"340_CR43","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.292.11.1317","volume":"292","author":"E Warner","year":"2004","unstructured":"Warner E, Plewes DB, Hill KA et al (2004) Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292(11):1317\u20131325. https:\/\/doi.org\/10.1001\/jama.292.11.1317","journal-title":"JAMA"},{"issue":"2","key":"340_CR44","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","volume":"57","author":"D Saslow","year":"2007","unstructured":"Saslow D, Boetes C, Burke W et al (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57(2):75\u201389. https:\/\/doi.org\/10.3322\/canjclin.57.2.75","journal-title":"CA Cancer J Clin"},{"key":"340_CR45","unstructured":"Australian Institute of Health and Welfare (2022) BreastScreen Australia monitoring report 2022. Australian Institute of Health and Welfare"},{"issue":"9","key":"340_CR46","doi-asserted-by":"publisher","first-page":"671","DOI":"10.7326\/0003-4819-148-9-200805060-00007","volume":"148","author":"E Warner","year":"2008","unstructured":"Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D (2008) Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 148(9):671\u2013679. https:\/\/doi.org\/10.7326\/0003-4819-148-9-200805060-00007","journal-title":"Ann Intern Med"},{"issue":"3","key":"340_CR47","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1056\/NEJMoa062790","volume":"356","author":"NF Boyd","year":"2007","unstructured":"Boyd NF, Guo H, Martin LJ et al (2007) Mammographic density and the risk and detection of breast cancer. N Engl J Med 356(3):227\u2013236. https:\/\/doi.org\/10.1056\/NEJMoa062790","journal-title":"N Engl J Med"},{"issue":"13","key":"340_CR48","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1093\/jnci\/92.13.1081","volume":"92","author":"MT Mandelson","year":"2000","unstructured":"Mandelson MT, Oestreicher N, Porter PL et al (2000) Breast density as a predictor of mammographic detection: comparison of interval-and screen-detected cancers. J Natl Cancer Inst 92(13):1081\u20131087","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"340_CR49","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13058-017-0859-9","volume":"19","author":"JOP Wanders","year":"2017","unstructured":"Wanders JOP, Holland K, Karssemeijer N et al (2017) The effect of volumetric breast density on the risk of screen-detected and interval breast cancers: a cohort study. Breast Cancer Res 19(1):67. https:\/\/doi.org\/10.1186\/s13058-017-0859-9","journal-title":"Breast Cancer Res"},{"issue":"6","key":"340_CR50","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/bcr1829","volume":"9","author":"CM Vachon","year":"2007","unstructured":"Vachon CM, van Gils CH, Sellers TA et al (2007) Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res 9(6):217. https:\/\/doi.org\/10.1186\/bcr1829","journal-title":"Breast Cancer Res"},{"issue":"12","key":"340_CR51","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1158\/1055-9965.2090.13.12","volume":"13","author":"E Ziv","year":"2004","unstructured":"Ziv E, Tice J, Smith-Bindman R, Shepherd J, Cummings S, Kerlikowske K (2004) Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiol Biomarkers Prev 13(12):2090\u20132095","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"340_CR52","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1158\/1055-9965.EPI-06-0034","volume":"15","author":"VA McCormack","year":"2006","unstructured":"McCormack VA, dos Santos Silva I (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15(6):1159\u20131169. https:\/\/doi.org\/10.1158\/1055-9965.EPI-06-0034","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"12","key":"340_CR53","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/s41416-018-0080-3","volume":"118","author":"M Rebolj","year":"2018","unstructured":"Rebolj M, Assi V, Brentnall A, Parmar D, Duffy SW (2018) Addition of ultrasound to mammography in the case of dense breast tissue: systematic review and meta-analysis. Br J Cancer 118(12):1559\u20131570. https:\/\/doi.org\/10.1038\/s41416-018-0080-3","journal-title":"Br J Cancer"},{"issue":"1","key":"340_CR54","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrclinonc.2011.173","volume":"9","author":"V Assi","year":"2012","unstructured":"Assi V, Warwick J, Cuzick J, Duffy SW (2012) Clinical and epidemiological issues in mammographic density. Nat Reviews Clin Oncol 9(1):33\u201340. https:\/\/doi.org\/10.1038\/nrclinonc.2011.173","journal-title":"Nat Reviews Clin Oncol"},{"issue":"21","key":"340_CR55","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1200\/JCO.2013.52.8331","volume":"32","author":"AM Chiarelli","year":"2014","unstructured":"Chiarelli AM, Prummel MV, Muradali D et al (2014) Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program. J Clin Oncol 32(21):2224\u20132230. https:\/\/doi.org\/10.1200\/JCO.2013.52.8331","journal-title":"J Clin Oncol"},{"issue":"3","key":"340_CR56","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s10549-016-3912-y","volume":"158","author":"AK Narayan","year":"2016","unstructured":"Narayan AK, Visvanathan K, Harvey SC (2016) Comparative effectiveness of breast MRI and mammography in screening young women with elevated risk of developing breast cancer: a retrospective cohort study. Breast Cancer Res Treat 158(3):583\u2013589. https:\/\/doi.org\/10.1007\/s10549-016-3912-y","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"340_CR57","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1200\/JCO.2009.23.0839","volume":"28","author":"C Kuhl","year":"2010","unstructured":"Kuhl C, Weigel S, Schrading S et al (2010) Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J Clin Oncol 28(9):1450\u20131457. https:\/\/doi.org\/10.1200\/JCO.2009.23.0839","journal-title":"J Clin Oncol"},{"issue":"12","key":"340_CR58","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1200\/JCO.18.00378","volume":"37","author":"VA Arasu","year":"2019","unstructured":"Arasu VA, Miglioretti DL, Sprague BL et al (2019) Population-Based Assessment of the Association between magnetic resonance imaging background parenchymal enhancement and future primary breast Cancer Risk. J Clin Oncol 37(12):954\u2013963. https:\/\/doi.org\/10.1200\/JCO.18.00378","journal-title":"J Clin Oncol"},{"issue":"5","key":"340_CR59","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.2214\/AJR.14.13047","volume":"204","author":"LJ Grimm","year":"2015","unstructured":"Grimm LJ, Anderson AL, Baker JA et al (2015) Interobserver variability between breast imagers using the Fifth Edition of the BI-RADS MRI Lexicon. AJR Am J Roentgenol 204(5):1120\u20131124. https:\/\/doi.org\/10.2214\/AJR.14.13047","journal-title":"AJR Am J Roentgenol"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-023-00340-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-023-00340-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-023-00340-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T14:54:49Z","timestamp":1695999289000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-023-00340-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,19]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["340"],"URL":"https:\/\/doi.org\/10.1007\/s10689-023-00340-5","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,19]]},"assertion":[{"value":"20 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. This study was approved by the Northern Sydney Local Health District Human Research Ethics Committee (NSLHD HREC) REGIS 2020\/ ETH00762.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individuals included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that patients signed informed consent regarding publishing their data and photographs.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}